APA (7th ed.) Citation

Zhou, Q., Xu, F., Wen, J., Yue, J., Zhang, Y., Du, L., . . . Liang, X. (2025). Tregs at Diagnosis as a Potential Biomarker for Predicting High‐Risk Functionality in Newly Diagnosed Multiple Myeloma. Cancer Medicine, 14(11), 1. https://doi.org/10.1002/cam4.70980

Chicago Style (17th ed.) Citation

Zhou, Qiaolin, et al. "Tregs at Diagnosis as a Potential Biomarker for Predicting High‐Risk Functionality in Newly Diagnosed Multiple Myeloma." Cancer Medicine 14, no. 11 (2025): 1. https://doi.org/10.1002/cam4.70980.

MLA (9th ed.) Citation

Zhou, Qiaolin, et al. "Tregs at Diagnosis as a Potential Biomarker for Predicting High‐Risk Functionality in Newly Diagnosed Multiple Myeloma." Cancer Medicine, vol. 14, no. 11, 2025, p. 1, https://doi.org/10.1002/cam4.70980.